Advertisement

Journal of Neural Transmission

, Volume 123, Issue 3, pp 339–352 | Cite as

Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression

  • Luana M. Manosso
  • Morgana Moretti
  • André R. Colla
  • Camille M. Ribeiro
  • Tharine Dal-Cim
  • Carla I. Tasca
  • Ana Lúcia S. RodriguesEmail author
Psychiatry and Preclinical Psychiatric Studies - Original Article

Abstract

Stress and excessive glutamatergic neurotransmission have been implicated in the pathophysiology of depression. Therefore, this study was aimed at investigating the influence of zinc on depressive-like behavior induced by chronic unpredictable stress (CUS), on alterations in glutamate-induced toxicity and immunocontent of proteins involved in the control of glutamatergic neurotransmission in the hippocampus of mice. Mice were subjected to CUS procedure for 14 days. From the 8th to the 14th day, mice received zinc chloride (ZnCl2) (10 mg/kg) or fluoxetine (10 mg/kg, positive control) once a day by oral route. CUS caused a depressive-like behavior evidenced by the increased immobility time in the tail suspension test (TST), which was prevented by treatment with ZnCl2 or fluoxetine. Ex vivo exposure of hippocampal slices to glutamate (10 mM) resulted in a significant decrease on cell viability; however, neither CUS procedure nor drug treatments altered this reduction. No alterations in the immunocontents of GLT-1 and GFAP or p-Akt were observed in any experimental group. The ratio of p-Akt/AKT was also not altered in any group. However, Akt immunocontent was increased in stressed mice and in animals treated with ZnCl2 (stressed or non-stressed mice) and EAAC1 immunocontent was increased in stressed mice treated with ZnCl2, fluoxetine or vehicle and in non-stressed mice treated with ZnCl2 and fluoxetine. These findings indicate a robust effect of zinc in reversing behavioral alteration induced by CUS in mice, through a possible modulation of the glutamatergic neurotransmission, extending literature data regarding the mechanisms underlying its antidepressant-like action.

Keywords

Antidepressant Glutamate Stress Tail suspension test Zinc 

Abbreviations

BDNF

Brain-derived neurotrophic factor

CUS

Chronic unpredictable stress

EAATs

Excitatory amino acid transporters

GFAP

Glial fibrillary acidic protein

MTT

3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide

NMDA

N-methyl-d-aspartate

OD

Optical density

p.o.

Per os

SEM

Standard error of the mean

TST

Tail suspension test

Notes

Acknowledgments

This study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) # 308723/2013-9 and # 449436/2014-4, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), NENASC Project (PRONEX-FAPESC/CNPq) # 1262/2012-9 and CAPES/PVE 052/2012.

References

  1. Autry AE, Grillo CA, Piroli GG, Rothstein JD, McEwen BS, Reagan LP (2006) Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus. Neuroendocrinology 83:371–379PubMedCrossRefGoogle Scholar
  2. Banasr M, Duman RS (2008) Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 64:863–870PubMedCentralPubMedCrossRefGoogle Scholar
  3. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15:501–511PubMedCentralPubMedCrossRefGoogle Scholar
  4. Barthel A, Ostrakhovitch EA, Walter PL, Kampkotter A, Klotz LO (2007) Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463:175–182PubMedCrossRefGoogle Scholar
  5. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354PubMedCrossRefGoogle Scholar
  6. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ (2011) Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16:634–646PubMedCentralPubMedCrossRefGoogle Scholar
  7. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137–151PubMedCrossRefGoogle Scholar
  8. Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ (2013) Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol 23:1443–1451PubMedCrossRefGoogle Scholar
  9. Bianchi MG, Bardelli D, Chiu M, Bussolati O (2014) Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease. Cell Mol Life Sci 71:2001–2015PubMedCrossRefGoogle Scholar
  10. Brocardo PS, Assini F, Franco JL, Pandolfo P, Muller YM, Takahashi RN, Dafre AL, Rodrigues AL (2007) Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain. Toxicol Sci 97:140–148PubMedCrossRefGoogle Scholar
  11. Charney DS, Manji HK (2004) Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2015:re5Google Scholar
  12. Chen Y, Swanson RA (2003) The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J Neurochem 84:1332–1339PubMedCrossRefGoogle Scholar
  13. Chen JX, Yao LH, Xu BB, Qian K, Wang HL, Liu ZC, Wang XP, Wang GH (2014) Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress. J Huazhong Univ Sci Technol Med Sci 34:838–844PubMedCrossRefGoogle Scholar
  14. Chesney E, Goodwin GM, Fazel S (2014) Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13:153–160PubMedCentralPubMedCrossRefGoogle Scholar
  15. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, Jones EG (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102:15653–15658PubMedCentralPubMedCrossRefGoogle Scholar
  16. Cichy A, Sowa-Kucma M, Legutko B, Pomierny-Chamiolo L, Siwek A, Piotrowska A, Szewczyk B, Poleszak E, Pilc A, Nowak G (2009) Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep 61:1184–1191PubMedCrossRefGoogle Scholar
  17. Cieslik K, Klenk-Majewska B, Danilczuk Z, Wrobel A, Lupina T, Ossowska G (2007) Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep 59:46–52PubMedGoogle Scholar
  18. Cieslik K, Sowa-Kucma M, Ossowska G, Legutko B, Wolak M, Opoka W, Nowak G (2011) Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep 63:537–543PubMedCrossRefGoogle Scholar
  19. Cordova FM, Rodrigues AL, Giacomelli MB, Oliveira CS, Posser T, Dunkley PR, Leal RB (2004) Lead stimulates ERK1/2 and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Res 998:65–72PubMedCrossRefGoogle Scholar
  20. Cunha MP, Machado DG, Bettio LE, Capra JC, Rodrigues AL (2008) Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 32:1913–1920PubMedCrossRefGoogle Scholar
  21. Doboszewska U, Sowa-Kucma M, Mlyniec K, Pochwat B, Holuj M, Ostachowicz B, Pilc A, Nowak G, Szewczyk B (2015) Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor. Prog Neuropsychopharmacol Biol Psychiatry 56:254–263PubMedCrossRefGoogle Scholar
  22. Dubey VK, Ansari F, Vohora D, Khanam R (2015) Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. J Trace Elem Med Biol 29:222–226PubMedCrossRefGoogle Scholar
  23. Duman RS (2014) Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety 31:291–296PubMedCentralPubMedCrossRefGoogle Scholar
  24. Duric V, Duman RS (2013) Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci 70:39–53PubMedCentralPubMedCrossRefGoogle Scholar
  25. Filho CB, Jesse CR, Donato F, Giacomeli R, Del Fabbro L, da Silva AM, de Gomes MG, Goes AT, Boeira SP, Prigol M, Souza LC (2015) Chronic unpredictable mild stress decreases BDNF and NGF levels and Na(+), K(+)-ATPase activity in the hippocampus and prefrontal cortex of mice: antidepressant effect of chrysin. Neuroscience 289:367–380PubMedCrossRefGoogle Scholar
  26. Franco JL, Posser T, Brocardo PS, Trevisan R, Uliano-Silva M, Gabilan NH, Santos AR, Leal RB, Rodrigues AL, Farina M, Dafre AL (2008) Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Behav Brain Res 188:316–323PubMedCrossRefGoogle Scholar
  27. Frederickson CJ, Suh SW, Silva D, Thompson RB (2000) Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130:1471S–1483SPubMedGoogle Scholar
  28. Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449–462PubMedCrossRefGoogle Scholar
  29. Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32:140–144PubMedCrossRefGoogle Scholar
  30. Garcia LS, Comim CM, Valvassori SS, Reus GZ, Stertz L, Kapczinski F, Gavioli EC, Quevedo J (2009) Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 33:450–455PubMedCrossRefGoogle Scholar
  31. Gourley SL, Espitia JW, Sanacora G, Taylor JR (2012) Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacology 219:805–814PubMedCentralPubMedCrossRefGoogle Scholar
  32. Gower-Winter SD, Levenson CW (2012) Zinc in the central nervous system: from molecules to behavior. BioFactors 38:186–193PubMedCentralPubMedCrossRefGoogle Scholar
  33. Hammen C (2005) Stress and depression. Annu Rev Clin Psychol 1:293–319PubMedCrossRefGoogle Scholar
  34. Hassan MA, Abdel Wahab WA, Elshafie T, Eid KA (2014) Serum level of zinc and copper as predictors of severity of depression in chronic hemodialysis patients. World J Med Sci 10:240–249Google Scholar
  35. Holmseth S, Dehnes Y, Huang YH, Follin-Arbelet VV, Grutle NJ, Mylonakou MN, Plachez C, Zhou Y, Furness DN, Bergles DE, Lehre KP, Danbolt NC (2012) The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS. J Neurosci 32:6000–6013PubMedCentralPubMedCrossRefGoogle Scholar
  36. Hughes EG, Maguire JL, McMinn MT, Scholz RE, Sutherland ML (2004) Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res Mol Brain Res 124:114–123PubMedCrossRefGoogle Scholar
  37. Imbe H, Kimura A, Donishi T, Kaneoke Y (2012) Chronic restraint stress decreases glial fibrillary acidic protein and glutamate transporter in the periaqueductal gray matter. Neuroscience 223:209–218PubMedCrossRefGoogle Scholar
  38. Irmisch G, Schlaefke D, Richter J (2010) Zinc and fatty acids in depression. Neurochem Res 35:1376–1383PubMedCrossRefGoogle Scholar
  39. Isingrini E, Camus V, Le Guisquet AM, Pingaud M, Devers S, Belzung C (2010) Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS One 5:e10404PubMedCentralPubMedCrossRefGoogle Scholar
  40. Jang BG, Won SJ, Kim JH, Choi BY, Lee MW, Sohn M, Song HK, Suh SW (2012) EAAC1 gene deletion alters zinc homeostasis and enhances cortical neuronal injury after transient cerebral ischemia in mice. J Trace Elem Med Biol 26:85–88PubMedCrossRefGoogle Scholar
  41. Jiang J, Amara SG (2011) New views of glutamate transporter structure and function: advances and challenges. Neuropharmacology 60:172–181PubMedCentralPubMedCrossRefGoogle Scholar
  42. Krizman-Genda E, Gonzalez MI, Zelenaia O, Robinson MB (2005) Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology 49:872–882PubMedCrossRefGoogle Scholar
  43. Kroczka B, Zieba A, Dudek D, Pilc A, Nowak G (2000) Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 52:403–406PubMedCrossRefGoogle Scholar
  44. Kroczka B, Branski P, Palucha A, Pilc A, Nowak G (2001) Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 55:297–300PubMedCrossRefGoogle Scholar
  45. Kumar B, Kuhad A, Chopra K (2011) Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology 214:819–828PubMedCrossRefGoogle Scholar
  46. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C (2010) Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res 44:808–816PubMedCrossRefGoogle Scholar
  47. Lee S, Chanoit G, McIntosh R, Zvara DA, Xu Z (2009) Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol 297:H569–H575PubMedCentralPubMedCrossRefGoogle Scholar
  48. Lehto SM, Ruusunen A, Tolmunen T, Voutilainen S, Tuomainen TP, Kauhanen J (2013) Dietary zinc intake and the risk of depression in middle-aged men: a 20-year prospective follow-up study. J Affect Disord 150:682–685PubMedCrossRefGoogle Scholar
  49. Levy LM, Lehre KP, Rolstad B, Danbolt NC (1993) A monoclonal antibody raised against an [Na(+)+K+]coupled l-glutamate transporter purified from rat brain confirms glial cell localization. FEBS Lett 317:79–84PubMedCrossRefGoogle Scholar
  50. Li LB, Toan SV, Zelenaia O, Watson DJ, Wolfe JH, Rothstein JD, Robinson MB (2006) Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem 97:759–771PubMedCrossRefGoogle Scholar
  51. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS (2011) Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754–761PubMedCentralPubMedCrossRefGoogle Scholar
  52. Liang D, Yang M, Guo B, Cao J, Yang L, Guo X, Li Y, Gao Z (2012) Zinc inhibits H(2)O(2)-induced MC3T3-E1 cells apoptosis via MAPK and PI3 K/AKT pathways. Biol Trace Elem Res 148:420–429PubMedCrossRefGoogle Scholar
  53. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC (2009) Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. Eur Neuropsychopharmacol 19:796–805PubMedCrossRefGoogle Scholar
  54. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC (2011) Glia atrophy in the hippocampus of chronic unpredictable stress-induced depression model rats is reversed by electroacupuncture treatment. J Affect Disord 128:309–313PubMedCrossRefGoogle Scholar
  55. Liu D, Xie K, Yang X, Gu J, Ge L, Wang X, Wang Z (2014) Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behav Brain Res 264:9–16PubMedCrossRefGoogle Scholar
  56. Lobato KR, Binfare RW, Budni J, Rosa AO, Santos AR, Rodrigues AL (2008) Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 32:994–999PubMedCrossRefGoogle Scholar
  57. Lu XY, Kim CS, Frazer A, Zhang W (2006) Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 103:1593–1598PubMedCentralPubMedCrossRefGoogle Scholar
  58. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349–358PubMedCrossRefGoogle Scholar
  59. Maes M, De Vos N, Demedts P, Wauters A, Neels H (1999) Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 56:189–194PubMedCrossRefGoogle Scholar
  60. Manosso LM, Moretti M, Ribeiro CM, Goncalves FM, Leal RB, Rodrigues AL (2015) Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation. Prog Neuropsychopharmacol Biol Psychiatry 59:59–67PubMedCrossRefGoogle Scholar
  61. Maserejian NN, Hall SA, McKinlay JB (2012) Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey. J Affect Disord 136:781–788PubMedCentralPubMedCrossRefGoogle Scholar
  62. Mathews DC, Henter ID, Zarate CA (2012) Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs 72:1313–1333PubMedCentralPubMedCrossRefGoogle Scholar
  63. Miguel-Hidalgo JJ, Waltzer R, Whittom AA, Austin MC, Rajkowska G, Stockmeier CA (2010) Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J Affect Disord 127:230–240PubMedCentralPubMedCrossRefGoogle Scholar
  64. Mlyniec K, Doboszewska U, Szewczyk B, Sowa-Kucma M, Misztak P, Piekoszewski W, Trela F, Ostachowicz B, Nowak G (2014) The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims. Neuropharmacology 79:290–297PubMedCrossRefGoogle Scholar
  65. Mlyniec K, Budziszewska B, Holst B, Ostachowicz B, Nowak G (2015a) GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus. Int J Neuropsychopharmacol 18:1–8Google Scholar
  66. Mlyniec K, Gawel M, Nowak G (2015b) Study of antidepressant drugs in GPR39 (zinc receptor(-)/(-)) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists. Behav Brain Res 287:135–138PubMedCrossRefGoogle Scholar
  67. Molz S, Decker H, Dal-Cim T, Cremonez C, Cordova FM, Leal RB, Tasca CI (2008) Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38 MAPK signaling. Neurochem Res 33:27–36PubMedCrossRefGoogle Scholar
  68. Molz S, Dal-Cim T, Budni J, Martin-de-Saavedra MD, Egea J, Romero A, del Barrio L, Rodrigues AL, Lopez MG, Tasca CI (2011) Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition. J Neurosci Res 89:1400–1408PubMedCrossRefGoogle Scholar
  69. Moretti M, Colla A, de Oliveira BG, dos Santos DB, Budni J, de Freitas AE, Farina M, Rodrigues AL (2012) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 46:331–340PubMedCrossRefGoogle Scholar
  70. Moretti M, Budni J, Freitas AE, Rosa PB, Rodrigues AL (2014) Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway. J Psychiatr Res 48:16–24PubMedCrossRefGoogle Scholar
  71. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63PubMedCrossRefGoogle Scholar
  72. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O’Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M (2014) Oxidative and nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46–62PubMedCrossRefGoogle Scholar
  73. Musholt K, Cirillo G, Cavaliere C, Rosaria Bianco M, Bock J, Helmeke C, Braun K, Papa M (2009) Neonatal separation stress reduces glial fibrillary acidic protein- and S100beta-immunoreactive astrocytes in the rat medial precentral cortex. Dev Neurobiol 69:203–211PubMedCrossRefGoogle Scholar
  74. Niciu MJ, Kelmendi B, Sanacora G (2012) Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav 100:656–664PubMedCentralPubMedCrossRefGoogle Scholar
  75. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, Lortet S (2006) The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem 98:1007–1018PubMedCrossRefGoogle Scholar
  76. Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A, Sadlik K, Piekoszewski W (2003) Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 61:159–164PubMedCrossRefGoogle Scholar
  77. Oliveira CS, Rigon AP, Leal RB, Rossi FM (2008) The activation of ERK1/2 and p38 mitogen-activated protein kinases is dynamically regulated in the developing rat visual system. Int J Dev Neurosci 26:355–362PubMedCrossRefGoogle Scholar
  78. Paoletti P, Vergnano AM, Barbour B, Casado M (2009) Zinc at glutamatergic synapses. Neuroscience 158:126–136PubMedCrossRefGoogle Scholar
  79. Peters S, Koh J, Choi DW (1987) Zinc selectively blocks the action of N-methyl-d-aspartate on cortical neurons. Science 236:589–593PubMedCrossRefGoogle Scholar
  80. Peterson GLA et al (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356PubMedCrossRefGoogle Scholar
  81. Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M, Nowak G (2014) Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol 17:393–405PubMedCrossRefGoogle Scholar
  82. Popoli M, Yan Z, McEwen BS, Sanacora G (2012) The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13:22–37Google Scholar
  83. Ranjbar E, Kasaei MS, Mohammad-Shirazi M, Nasrollahzadeh J, Rashidkhani B, Shams J, Mostafavi SA, Mohammadi MR (2013) Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry 8:73–79PubMedCentralPubMedGoogle Scholar
  84. Ranjbar E, Shams J, Sabetkasaei M, M-Shirazi M, Rashidkhani B, Mostafavi A, Bornak E, Nasrollahzadeh J (2014) Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci 17:65–71PubMedCrossRefGoogle Scholar
  85. Raudensky J, Yamamoto BK (2007) Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res 1135:129–135PubMedCentralPubMedCrossRefGoogle Scholar
  86. Reagan LP, Rosell DR, Wood GE, Spedding M, Munoz C, Rothstein J, McEwen BS (2004) Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 101:2179–2184PubMedCentralPubMedCrossRefGoogle Scholar
  87. Reus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J (2011) Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res 221:166–171PubMedCrossRefGoogle Scholar
  88. Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL (2003) Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144:87–93PubMedCrossRefGoogle Scholar
  89. Rosa JM, Dafre AL, Rodrigues AL (2013) Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation. Behav Brain Res 253:165–172PubMedCrossRefGoogle Scholar
  90. Ruhe HG, van Rooijen G, Spijker J, Peeters FP, Schene AH (2011) Staging methods for treatment resistant depression: a systematic review. J Affect Disord 137:35–45PubMedCrossRefGoogle Scholar
  91. Ryu JM, Lee MY, Yun SP, Han HJ (2009) Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR. J Cell Physiol 218:558–567PubMedCrossRefGoogle Scholar
  92. Sanacora G, Banasr M (2013) From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 73:1172–1179PubMedCentralPubMedCrossRefGoogle Scholar
  93. Siwek M, Dudek D, Paul IA, Sowa-Kucma M, Zieba A, Popik P, Pilc A, Nowak G (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118:187–195PubMedCrossRefGoogle Scholar
  94. Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G (2010) Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord 126:447–452PubMedCrossRefGoogle Scholar
  95. Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR (2014) Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Nutr Neurosci 18:162–168PubMedCrossRefGoogle Scholar
  96. Soni N, Reddy BV, Kumar P (2014) GLT-1 transporter: an effective pharmacological target for various neurological disorders. Pharmacol Biochem Behav 127:70–81PubMedCrossRefGoogle Scholar
  97. Sowa-Kucma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G (2008) Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm 115:1621–1628PubMedCrossRefGoogle Scholar
  98. Sowa-Kucma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W, Poleszak E, Pilc A, Nowak G (2013) Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord 151:924–931PubMedCrossRefGoogle Scholar
  99. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370PubMedCrossRefGoogle Scholar
  100. Swardfager W, Herrmann N, McIntyre RS, Mazereeuw G, Goldberger K, Cha DS, Schwartz Y, Lanctot KL (2013) Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neurosci Biobehav Rev 37:911–929PubMedCrossRefGoogle Scholar
  101. Szewczyk B, Poleszak E, Wlaz P, Wrobel A, Blicharska E, Cichy A, Dybala M, Siwek A, Pomierny-Chamiolo L, Piotrowska A, Branski P, Pilc A, Nowak G (2009) The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 33:323–329PubMedCrossRefGoogle Scholar
  102. Talarowska M, Bobinska K, Zajaczkowska M, Su KP, Maes M, Galecki P (2014) Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders. Med Sci Monit 20:110–115PubMedCentralPubMedCrossRefGoogle Scholar
  103. Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S (2014) Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat 10:2097–2103PubMedCentralPubMedGoogle Scholar
  104. Vandenberg RJ, Ryan RM (2013) Mechanisms of glutamate transport. Physiol Rev 93:1621–1657PubMedCrossRefGoogle Scholar
  105. Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, Attia J (2014) Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord 166:249–257PubMedCrossRefGoogle Scholar
  106. Willner P (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134:319–329PubMedCrossRefGoogle Scholar
  107. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90–110PubMedCrossRefGoogle Scholar
  108. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358–364PubMedCrossRefGoogle Scholar
  109. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525–534PubMedCrossRefGoogle Scholar
  110. Won SJ, Yoo BH, Brennan AM, Shin BS, Kauppinen TM, Berman AE, Swanson RA, Suh SW (2010) EAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemia. J Neurosci 30:15409–15418PubMedCrossRefGoogle Scholar
  111. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856–864PubMedCrossRefGoogle Scholar
  112. Zhang XH, Jia N, Zhao XY, Tang GK, Guan LX, Wang D, Sun HL, Li H, Zhu ZL (2013) Involvement of pGluR1, EAAT2 and EAAT3 in offspring depression induced by prenatal stress. Neuroscience 250:333–341PubMedCrossRefGoogle Scholar
  113. Zhang Y, Liu L, Liu YZ, Shen XL, Wu TY, Zhang T, Wang W, Wang YX, Jiang CL (2015) NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol 18:1–8CrossRefGoogle Scholar
  114. Zhou Y, Danbolt NC (2013) GABA and glutamate transporters in brain. Front Endocrinol (Lausanne) 4:165Google Scholar
  115. Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA (2010) Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 58:465–473PubMedCrossRefGoogle Scholar
  116. Zink M, Rapp S, Donev R, Gebicke-Haerter PJ, Thome J (2011) Fluoxetine treatment induces EAAT2 expression in rat brain. J Neural Transm 118:849–855PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2016

Authors and Affiliations

  • Luana M. Manosso
    • 1
  • Morgana Moretti
    • 1
    • 2
  • André R. Colla
    • 1
  • Camille M. Ribeiro
    • 1
  • Tharine Dal-Cim
    • 1
  • Carla I. Tasca
    • 1
  • Ana Lúcia S. Rodrigues
    • 1
    Email author
  1. 1.Department of Biochemistry, Center of Biological SciencesUniversidade Federal de Santa CatarinaFlorianópolisBrazil
  2. 2.Post-Graduate Nutrition Program, Center of Health SciencesUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations